Source: Biotechnology Progress. Unidade: FCFRP
Subjects: NEOPLASIAS OVARIANAS, FÁRMACOS, BIOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOFANI, Larissa Bueno et al. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, v. 36, n. 6, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1002/btpr.3034. Acesso em: 02 nov. 2024.APA
Tofani, L. B., Abriata, J. P., Luiz, M. T., Marchetti, J. M., & Swiech, K. (2020). Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, 36( 6), 1-11. doi:10.1002/btpr.3034NLM
Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1002/btpr.3034Vancouver
Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1002/btpr.3034